Tempe, Arizona based SDCmaterials, the global leader in development of advanced high performance catalyst materials, is pleased to announce the commencement of field trials for their novel Nano-Nano-Micron (NNm) emission control catalyst product.
Intertek Cantox, a leading provider of scientific and regulatory consulting services to the food, chemical, and pharmaceutical industries, announces the development of a method to promote high quality nanotoxicology studies allowing companies to ensure the safety of nanotechnology and nanomaterials based products entering the market.
Blend Therapeutics, a biotechnology company discovering and developing a new class of integrative combination medicines, announced the company's founding and strategic mission to develop innovative combination medicines with novel pharmacological profiles designed to target distinct disease pathways with optimal efficacy and safety.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and Arrowhead Research Corporation, a nanomedicine company with development programs in RNAi and obesity, announced today that they have entered into a collaboration and joint licensing agreement.
Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.
AMETEK, Inc. today announced that it has acquired Technical Manufacturing Corporation (TMC), a world leader in high-performance vibration isolation systems and optical test benches used to isolate highly sensitive instruments for the microelectronics, life sciences, photonics and ultra-precision manufacturing industries.
Tomowave Laboratories, Inc, announces award of a Small Business Innovation Research (SBIR) Phase I grant from the National Institute of Environmental Health Sciences to investigate the potential health risks of nanotechnology applications in industry and medicine.
GMZ's drive to commercialize direct heat-to-electricity conversion backed by Mitsui Ventures, I2BF Global Ventures, GE-NRG Energy-ConocoPhillips' Venture, Kleiner Perkins Caufield and Byers, and BP Alternative Energy.
A US$100m nanotechnology venture fund has been announced by joint managers VTB Capital and I2BF Global Ventures, with cornerstone backing from the Russian state nanotechnology fund RusNano and Kazyna Capital Management, the sovereign wealth fund of the Republic of Kazakhstan.
UC RUSAL, the world's largest aluminium producer, and RUSNANO announce that RUSAL's IRKAZ, an aluminium smelter based in Irkutsk, and specialists from RUSAL's Engineering and Technology Center, have successfully tested Nanocomp Metcast, nanocoatings developed by RUSNANO's project company ItN Nanovation AG.
Imec is working together with Flamac to develop novel semiconductor materials for solar cell applications. Within this collaboration novel materials are screened as an alternative for the standard solar cells made of copper indium gallium and selenium (CIGS).
Natcore Technology Inc. has been granted a patent license agreement from the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) to develop and commercialize a line of black silicon products--including equipment, chemicals, and solar cells---based on NREL patents. The license grants Natcore exclusivity in the field of diffused emitters with liquid phase passivation.